SCHEMBL26619620

SCHEMBL26619620

CC(C)(C)OC(=O)N[C@H](C(=O)O)[C@H]1CCCc2ccccc21

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.43
MAPK1 P28482 1/20 0.42
MAPK14 Q16539 1/20 0.42
IDO1 P14902 1/20 0.42
TSHR P16473 1/20 0.41
HTT P42858 1/20 0.41
DRD2 P14416 3/20 0.41
CTSL P07711 2/20 0.40
CTSK P43235 2/20 0.40
RAB9A P51151 1/20 0.40
SCN9A Q15858 1/20 0.39
CTSV O60911 1/20 0.39
CTSS P25774 1/20 0.39
LMNA P02545 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
ACE P12821 1/20 0.39
USP2 O75604 1/20 0.39
ECE1 P42892 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29535205 1.00 ALDH1A1 (0.43) ALDH1A1MAPK1MAPK14IDO1TSHR
SCHEMBL26619622 1.00 ALDH1A1 (0.43) ALDH1A1MAPK1MAPK14IDO1TSHR
SCHEMBL14453238 0.93 IDO1 (0.43) MAPK1IDO1DRD2CTSLCTSK
SCHEMBL31757931 0.93 IDO1 (0.43) MAPK1IDO1DRD2CTSLCTSK
SCHEMBL31757939 0.93 IDO1 (0.43) MAPK1IDO1DRD2CTSLCTSK
SCHEMBL24593697 0.84 MMP13 (0.38) CTSKRAB9ASCN9ACTSS
SCHEMBL22143906 0.84 AAK1 (0.48) CTSLCTSKRAB9ACTSS
SCHEMBL22409744 0.84 AAK1 (0.48) CTSLCTSKRAB9ACTSS
SCHEMBL22425331 0.84 AAK1 (0.48) CTSLCTSKRAB9ACTSS
SCHEMBL22143651 0.84 AAK1 (0.48) CTSLCTSKRAB9ACTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023209519-A1 CRYSTALLINE FORMS OF AN IL-17 INHIBITOR NOVARTIS AG (CH) 2023-11-02 WO disclosed
CN-116323596-A Interleukin-17 inhibitors 诺华股份有限公司 2023-06-23 CN disclosed